Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
(Adnkronos) – LEIDEN, Netherlands, April 11, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commercial shipments of Joenja® (leniolisib) to patients in the United States.
